Patients aged > or = 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy.

Publication Type:

Journal Article

Source:

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Volume 19, Issue 5, p.1583-5 (2001)

Keywords:

Age Factors, Aged, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Doxorubicin, Granulocyte Colony-Stimulating Factor, Humans, INFECTION, NEUTROPENIA, Practice Guidelines as Topic, Prednisone, Risk Factors, Vincristine